Clinical Trial Update: Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension [Phase 3]

View source ↗

Summary

Phase 3 safety and efficacy study of the fixed combination of brimonidine and timolol in glaucoma or ocular hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Combigan (brimonidine tartrate and timolol maleate)

Snippet

Sponsor: Allergan | Conditions: Ocular Hypertension | Phase 3 | Status: COMPLETED